[THERAPEUTIC EVALUATION OF TERALENE IN THE TREATMENT OF DEPRESSIVE CONDITIONS] [0.03%]
特拉莱恩治疗抑郁状态的疗效评价
V M SHAMANINA,G I ZAVIDOVSKAIA
V M SHAMANINA
[APROPOS OF THE ANTICOAGULANT THERAPY OF PATIENTS IN THE ACUTE PHASE OF CEREBRAL INFARCTION] [0.03%]
关于脑梗死急性期患者抗凝治疗的问题
S V BABENKOVA,V M KARPINSKAIA
S V BABENKOVA
[AMINAZIN THERAPY OF STUPOROUS CONDITIONS. (CLINICO-PHYSIOLOGICAL ANALYSIS)] [0.03%]
【氨甲嗪治疗昏迷状态的临床生理学分析】
L A SHMILOVICH,A I POLIAK,T N NAZAROVA
L A SHMILOVICH
[BIOCHEMICAL AND PATHOPHYSIOLOGICAL STUDY OF THE ALLERGIC COMPONENT IN THE PATHOGENESIS OF SCHIZOPHRENIA AND INFECTIOUS PSYCHOSES] [0.03%]
[精神分裂症和感染性精神病发病机理中过敏因素的生化和病理生理学研究]
V S SHAPOSHNIKOV
V S SHAPOSHNIKOV
[EVALUATION OF THE ACTIVITY OF ENZYMES AND BILIRUBIN IN THE DIAGNOSIS OF LIVER DISEASES IN SCHIZOPHRENICS] [0.03%]
[酶及胆红素活性在精神分裂症肝病诊断中的作用评价]
M K TSAUNE,Z P IAKSON,A K PILIPENKO
M K TSAUNE